Partial year: Data through Q3 2025 (Sept 30). Full-year totals not yet available.
AS

Angelica Sanabria

IB Inhibrx Biosciences: 3 patents #7 of 23Top 35%
RP Regeneron Pharmaceuticals: 1 patents #121 of 345Top 40%
📍 Village of La Jolla, CA: #29 of 352 inventorsTop 9%
🗺 California: #5,745 of 55,090 inventorsTop 15%
Overall (2025): #67,927 of 469,880Top 15%
3
Patents 2025

Issued Patents 2025

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
12421315 CLL-1 targeted immunotherapies Jordan Jarjour, Mark Pogson, Wai-Hang Leung, Lucas Rascon, John C. Timmer +1 more 2025-09-23
12365728 DLL3 single domain antibodies and therapeutic compositions thereof Brendan P. Eckelman, Michael D. KAPLAN, Katelyn M. Willis, Rajay Pandit, Sydney A. Barnes +2 more 2025-07-22
12297271 PD-1 single domain antibodies and therapeutic compositions thereof Rajay Pandit, John C. Timmer, Florian Sulzmaier, Brendan P. Eckelman 2025-05-13